scanX
Dishman Carbogen Amcis
add_icon

Dishman Carbogen Amcis

189.88
-2.06
(-1.07%)
Market Cap
2,977.00 Cr
PE Ratio
30.85
Volume
1,85,064.00
Day High - Low
195.50 - 188.90
52W High-Low
321.95 - 128.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,977.00 Cr
EPS
6.22
PE Ratio
30.85
PB Ratio
0.45
Book Value
425.87
EBITDA
561.83
Dividend Yield
0.00 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
0.06
Debt to Equity
0.41
Forecast For
Actual

Company News

View All News
Caret
negative
Dishman Carbogen Q4 Net Profit Drops to 217M RupeesMay 20, 2026
Dishman Carbogen Q4 consolidated net profit fell to 217M rupees from 431M YoY, while revenue rose to 8.51B rupees from 7.16B. EBITDA margin contracted to 19.2% from 21.3%.
neutral
Dishman Carbogen Amcis Q4FY26 Earnings Call Set for May 20May 19, 2026
Dishman Carbogen Amcis schedules Q4FY26 & FY26 earnings conference call on May 20, 2026, at 15:00 hrs IST, with Global CFO and CEO of Carbogen Amcis Entities.
positive
Dishman Carbogen Amcis Shanghai Site Clears NMPA GMP InspectionMay 06, 2026
CARBOGEN AMCIS Shanghai facility successfully completed an unannounced GMP inspection by China's NMPA on 14 April 2026, with no observations identified.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,782.20
#1 4,27,609.48
37.09
#1 58,220.10
6.38
#1 11,565
25.80
43.33
Divis Laboratories
6,623.00
1,75,819.84
68.17
10,560.00
8.73
2,520
13.44
49.66
Torrent Pharmaceuticals
4,420.90
1,49,623.34
68.66
13,886.20
20.34
2,138
-26.91
53.32
Cipla
1,401.30
1,13,194.31
29.24
27,711.70
-2.46
3,783
-55.32
58.57
Zydus Life Science
1,089.00
1,09,578.88
21.32
26,719.70
13.65
5,242
7.82
71.01
Dr Reddys Laboratories
1,278.20
1,06,684.07
25.44
33,593.30
-0.44
3,998
-86.05
45.82
Lupin
2,267.70
1,03,643.69
#1 19.20
27,487.50
19.98
5,345
#1 87.72
47.04
Mankind Pharma
2,336.10
96,435.39
50.16
14,277.60
12.03
1,750
31.75
47.08
Aurobindo Pharma
1,462.30
84,930.62
24.27
33,384.70
3.21
3,376
1.99
53.78
Laurus Labs
1,446.80
78,106.45
86.55
6,812.90
#1 21.03
884
21.18
80.98
Growth Rate
Revenue Growth
7.27 %
Net Income Growth
1,331.87 %
Cash Flow Change
-1.11 %
ROE
-102.20 %
ROCE
-7,466.67 %
EBITDA Margin (Avg.)
4.74 %

Quarterly Financial Results

Quarterly Financials
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
419
368
440
372
491
345
440
446
468
455
447
441
631
509
456
528
533
483
454
478
535
561
469
581
573
546
623
646
625
730
595
657
662
525
796
690
724
733
661
727
868
Expenses
318
271
321
263
388
270
311
339
330
362
319
346
480
403
322
417
405
431
359
406
463
450
362
453
559
452
535
529
613
602
529
610
595
500
645
542
575
570
504
607
690
EBITDA
101
97
118
109
103
75
129
107
138
93
128
95
151
107
135
111
128
52
95
72
72
111
106
129
14
94
88
118
13
128
66
47
67
25
151
148
149
163
157
120
178
Operating Profit %
22 %
25 %
25 %
26 %
20 %
20 %
28 %
21 %
27 %
19 %
26 %
19 %
21 %
20 %
29 %
20 %
21 %
9 %
18 %
13 %
12 %
18 %
21 %
19 %
2 %
16 %
13 %
17 %
1 %
17 %
10 %
6 %
9 %
4 %
18 %
21 %
20 %
19 %
23 %
16 %
19 %
Depreciation
30
51
55
51
57
51
55
55
51
54
58
58
71
67
70
72
74
74
78
79
77
75
74
75
84
75
80
50
76
70
75
80
85
71
72
72
79
81
84
84
89
Interest
21
23
20
13
10
11
13
13
11
15
15
14
13
14
17
11
20
12
13
14
9
12
14
15
16
19
20
22
24
29
28
33
31
32
37
49
42
43
42
46
43
Profit Before Tax
67
36
51
50
83
14
74
68
75
58
71
75
106
46
65
51
35
-34
4
-22
-14
24
19
39
-85
-0
-12
46
-88
30
-36
-66
-49
-78
42
27
28
39
31
-10
46
Tax
17
6
13
17
40
1
26
26
24
18
27
23
30
12
24
18
-15
-12
-3
-6
121
8
7
3
-41
-4
-2
-1
-17
13
5
-7
21
0
9
22
-15
15
-35
3
24
Net Profit
50
30
38
33
43
13
48
42
51
40
44
51
76
34
41
33
50
-21
7
-16
-135
16
11
35
-45
4
-10
47
-71
17
-41
-60
-70
-78
33
5
43
23
65
-13
22
EPS in ₹
6.17
1.88
2.37
2.01
2.65
0.81
3.00
2.60
3.17
2.46
2.73
3.18
4.70
2.13
2.55
2.04
3.11
-1.37
0.47
-1.02
-8.61
1.02
0.71
2.26
-2.85
0.26
-0.64
3.00
-4.51
1.08
-2.61
-3.80
-4.46
-4.95
2.11
0.30
2.75
1.49
4.16
-0.83
1.39
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
6,593
7,177
7,329
8,200
8,366
8,638
9,454
9,581
9,999
11,923
Fixed Assets
4,852
5,066
5,098
5,678
5,698
5,773
6,188
6,724
7,055
3,848
Current Assets
1,245
1,546
1,554
1,779
1,704
1,839
1,918
1,928
2,200
2,842
Capital Work in Progress
133
151
175
234
486
780
1,043
646
467
275
Investments
40
196
167
191
172
324
249
102
97
1,019
Other Assets
1,569
1,764
1,889
2,097
2,010
1,761
1,973
2,109
2,380
0
Total Equity & Liabilities
6,593
7,177
7,329
8,200
8,366
8,638
9,454
9,581
9,999
11,923
Current Liabilities
994
1,178
1,198
1,569
1,290
1,420
1,798
2,555
1,925
2,317
Non Current Liabilities
786
891
751
916
1,377
1,669
1,845
1,399
2,243
2,929
Total Equity
4,814
5,107
5,379
5,715
5,699
5,549
5,810
5,628
5,832
6,677
Reserve & Surplus
4,814
5,075
5,347
5,684
5,668
5,518
5,778
5,596
5,800
6,646
Share Capital
0
32
32
31
31
31
31
31
31
31
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2011
2012
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-3
-19
59
7
11
46
122
-133
22
132
77
Investing Activities
-231
-104
-107
-297
-169
-442
-380
-619
-494
-225
-196
Operating Activities
203
154
303
226
282
585
513
355
266
379
375
Financing Activities
26
-68
-137
78
-102
-98
-11
130
250
-22
-102
Above figures are in Rs. Crores

Share Holding

% Holding
Apr 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
63.17 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
59.32 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.80 %
8.61 %
8.70 %
8.04 %
8.17 %
8.74 %
9.49 %
9.93 %
8.07 %
7.66 %
7.45 %
DIIs
12.80 %
8.85 %
6.66 %
6.05 %
6.18 %
6.75 %
6.54 %
4.28 %
3.87 %
2.56 %
3.14 %
3.52 %
3.69 %
2.37 %
1.48 %
1.23 %
1.42 %
1.26 %
1.27 %
1.37 %
1.27 %
1.63 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.93 %
21.60 %
22.62 %
24.75 %
24.20 %
23.55 %
23.73 %
25.85 %
25.66 %
24.61 %
24.57 %
24.64 %
24.54 %
25.17 %
27.10 %
27.43 %
26.22 %
25.31 %
25.36 %
26.84 %
27.31 %
27.20 %
Others
13.09 %
10.24 %
11.40 %
9.87 %
10.30 %
10.37 %
10.42 %
10.55 %
11.15 %
13.50 %
12.97 %
3.72 %
3.85 %
4.45 %
4.06 %
3.85 %
4.29 %
4.62 %
4.11 %
4.39 %
4.44 %
4.40 %
No of Share Holders
43,186
58,738
54,077
60,726
54,662
56,322
56,986
59,654
61,175
56,583
56,221
56,272
52,336
50,656
53,683
55,280
52,822
50,757
49,744
49,455
48,481
49,009

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1.2 0.00 0.2 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.37 0.00 0.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Jun 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 19 Jun 2026 199.70 190.10
27 Mar 2017 CHANGE OF NAME Change Of Name
NA
 27 Mar 2017 0.00 0.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 27 Sept 2024 192.15 182.94
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Nov 2024 195.16 190.65
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Feb 2025 245.20 230.55
21 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 21 May 2025 215.45 218.29
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 241.95 240.00
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Sept 2025 270.15 280.50
04 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Nov 2025 292.95 291.65
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 03 Feb 2026 206.05 215.40
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2026 176.10 187.80

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance6 days ago
Publication Of Newspaper Advertisement Regarding Intimation Of Extra-Ordinary General Meeting And E-Voting Instructions In Respect Of EGM To Be Held On 19Th June 2026.8 days ago
SUBMISSION OF NOTICE OF EXTRA-ORDINARY GENERAL MEETING (EGM) AS PER REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 20159 days ago
Publication Of Newspaper Advertisement Regarding Intimation Of Extra-Ordinary General Meeting9 days ago
Intimation Regarding Date Of Extra-Ordinary General Meeting10 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 19, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 19Th May 2026.May 19, 2026
Outcome Of Board Meeting Held On 19Th May 2026.May 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2026
Board Meeting Intimation for Considering Take On Record & Approve The Audited Financial Results Of The Company For The Quarter And Year Ended 31/03/2026 & To Consider Evaluate And Approve The Proposal Of Availing ECB In The Form Of Unsecured Loan(S) From May 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015 : Amendment In Terms Related To Financial Covenants For FY Ended 31St March 2026 In Respect Of Non-Convertible Debentures (NCDS) Issued Under ISIN INE385W07059Apr 02, 2026
Closure of Trading WindowMar 25, 2026
Board Meeting Outcome for BOARD APPROVES ISSUE OF SENIOR SECURED RATED LISTED REDEEMABLE TRANSFERABLE TAXABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 150 CRORESMar 18, 2026
Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be RequiredMar 15, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 23, 2026
DISCLOSURE PURSUANT TO REGULATIONS 30 AND 51 OF SEBI (LODR) REGULATIONS 2015: COMPANYS WHOLLY-OWNED SUBSIDIARY VIZ. CARBOGEN AMCIS B.V. RECEIVED CERTIFICATE OF GMP COMPLIANCE FOR ITS VEENENDAAL SITE NETHERLANDS.Feb 20, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2026
Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2025Feb 03, 2026
UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2025Feb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Considering Take On Record And Approve The Un-Audited Financial Results Of The Company For The Third Quarter Ended On 31St December 2025Jan 29, 2026
Announcement under Regulation 30 (LODR)-AllotmentJan 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 06, 2026
Board Meeting Outcome for BOARD MEETING OUTCOME FOR BOARD APPROVES ISSUE OF SENIOR SECURED RATED LISTED TRANSFERABLE TAXABLE REDEEMABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 50 CRORESDec 27, 2025
Closure of Trading WindowDec 23, 2025
Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be RequiredDec 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 05, 2025
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025.Nov 04, 2025
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025.Nov 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Board Meeting Intimation for Considering Take On Record And Approving The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025Oct 30, 2025
INTIMATION OF MERGER OF TWO MATERIAL WHOLLY-OWNED STEP-DOWN SUBSIDIARIES OF THE COMPANYOct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 07, 2025

Technical Indicators

Bearish
0
Neutral
0
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104